Works about IMIQUIMOD

Results: 218

Development of a psoriatic-like skin inflammation rat model using imiquimod as an inducing agent.

Published in:

Indian Journal of Pharmacology, 2021, v. 53, n. 2, p. 125, doi. 10.4103/ijp.IJP_506_19

By:

Parmar, Komal M.;
Jagtap, Chetan S.;
Katare, Nitin T.;
Dhobi, Mahaveer;
Prasad, Satyendra K.

Publication type:

Article

Birinapant improves imiquimod-induced psoriasis in BALB/c mice.

Published in:

Immunopharmacology & Immunotoxicology, 2025, v. 47, n. 2, p. 239, doi. 10.1080/08923973.2025.2470345

By:

Parab, Siddhi;
Doshi, Gaurav

Publication type:

Article

Treatment of solar lentigo with imiquimod 3.75% cream: A dermoscopic study.

Published in:

Journal of Cosmetic Dermatology, 2022, v. 21, n. 11, p. 6487, doi. 10.1111/jocd.15177

By:

Di Bartolomeo, Luca;
Guarneri, Fabrizio;
Moretti, Giovanna

Publication type:

Article

The combined effect of CO<sub>2</sub> laser, topical diclofenac 3%, and imiquimod 5% in treating high‐risk basal cell carcinoma.

Published in:

Journal of Cosmetic Dermatology, 2022, v. 21, n. 5, p. 2049, doi. 10.1111/jocd.14354

By:

El‐Khalawany, Mohamed;
Saudi, Wael M.;
Ahmed, Eman;
Mosbeh, Alsadat;
Sameh, Ahmed;
Rageh, Mahmoud A.

Publication type:

Article

Comparative study of imiquimod 3.75% vs. photodynamic therapy for actinic keratosis of the scalp.

Published in:

Photodermatology, Photoimmunology & Photomedicine, 2021, v. 37, n. 5, p. 404, doi. 10.1111/phpp.12671

By:

Cortelazzi, Chiara;
Odorici, Giulia;
Castagnetti, Elisa;
Pellacani, Giovanni;
Di Nuzzo, Sergio

Publication type:

Article

Etanercept alleviates psoriasis by reducing the Th17/Treg ratio and promoting M2 polarization of macrophages.

Published in:

Immunity, Inflammation & Disease, 2022, v. 10, n. 12, p. 1, doi. 10.1002/iid3.734

By:

Li, Xiaoqing;
Jiang, Ming;
Chen, Xia;
Sun, Weiguo

Publication type:

Article

Imiquimod induced vitiligo‐like lesions—A consequence of modified melanocyte function.

Published in:

Immunity, Inflammation & Disease, 2022, v. 10, n. 1, p. 70, doi. 10.1002/iid3.543

By:

Yu, Haiyan;
Cen, Jianping;
Lin, Xiaoxia;
Cheng, Hao;
Seifert, Oliver

Publication type:

Article

Oestrogen inhibits psoriasis‐like dermatitis induced by imiquimod in mice in relation to increased IL‐10 producing cells despite elevated expression of IL‐22, IL‐23, IL‐17 mRNA.

Published in:

Experimental Dermatology, 2023, v. 32, n. 2, p. 203, doi. 10.1111/exd.14688

By:

Kobayashi, Keisuke;
Chikazawa, Sakiko;
Chen, Yue;
Suzuki, So;
Ichimasu, Nao;
Katagiri, Kazumoto

Publication type:

Article

Early redox homeostasis disruption contributes to the differential cytotoxicity of imiquimod on transformed and normal endothelial cells.

Published in:

Experimental Dermatology, 2022, v. 31, n. 4, p. 608, doi. 10.1111/exd.14499

By:

Rocco, Rodrigo;
Cambindo Botto, Adrián E.;
Muñoz, Manuel J.;
Reingruber, Hernán;
Wainstok, Rosa;
Cochón, Adriana;
Gazzaniga, Silvina

Publication type:

Article

Methodological shortcomings in the reports of the imiquimod psoriatic model.

Published in:: Experimental Dermatology, 2022, v. 31, n. 3, p. 299, doi. 10.1111/exd.14479
Publication type:: Article

Poly(ADP‐ribose) polymerase‐1 depletion enhances the severity of inflammation in an imiquimod‐induced model of psoriasis.

Published in:

Experimental Dermatology, 2020, v. 29, n. 1, p. 79, doi. 10.1111/exd.14061

By:

Kiss, Borbála;
Szántó, Magdolna;
Hegedűs, Csaba;
Antal, Dóra;
Szödényi, Annamária;
Márton, Judit;
Méhes, Gábor;
Virág, László;
Szegedi, Andrea;
Bai, Péter

Publication type:

Article

Imiquimod‐induced skin inflammation is relieved by knockdown of sodium channel Na<sub>x</sub>.

Published in:

Experimental Dermatology, 2019, v. 28, n. 5, p. 576, doi. 10.1111/exd.13917

By:

Zhao, Jingling;
Xie, Ping;
Galiano, Robert D.;
Qi, Shaohai;
Mao, Renxiang;
Mustoe, Thomas A.;
Hong, Seok Jong

Publication type:

Article

5‐hydroxytryptophan attenuates imiquimod‐induced psoriasiform dermatitis probably through inhibition of IL‐17A production and keratinocyte activation.

Published in:

Experimental Dermatology, 2018, v. 27, n. 11, p. 1273, doi. 10.1111/exd.13781

By:

Hsu, Peng‐Yang;
Su, Che‐Chun;
Yang, Hui‐Ju;
Yang, Tao‐Hsiang

Publication type:

Article

Local production of prolactin in lesions may play a pathogenic role in psoriatic patients and imiquimod‐induced psoriasis‐like mouse model.

Published in:

Experimental Dermatology, 2018, v. 27, n. 11, p. 1245, doi. 10.1111/exd.13772

By:

Yang, Hui;
Li, Xia;
Xia, Qunli;
Zhao, Xin;
Wang, Dixin;
Chen, Lihong;
Cao, Hua;
Xu, Han;
Shen, Xiaoyan;
Yuan, Weiru;
Zhao, Xiaoqing;
Shi, Ruofei;
Zheng, Jie;
Xue, Feng

Publication type:

Article

Mild electrical stimulation with heat shock reduces inflammatory symptoms in the imiquimod‐induced psoriasis mouse model.

Published in:

Experimental Dermatology, 2018, v. 27, n. 10, p. 1092, doi. 10.1111/exd.13720

By:

Tsurekawa, Yu;
Morita, Misaki;
Suico, Mary Ann;
Moriuchi, Masataka;
Nakano, Yoshio;
Piruzyan, Mariam;
Takada, Masafumi;
Fukami, Sanako;
Shuto, Tsuyoshi;
Kai, Hirofumi

Publication type:

Article

Altered expression of matrix remodelling associated 7 (MXRA7) in psoriatic epidermis: Evidence for a protective role in the psoriasis imiquimod mouse model.

Published in:

Experimental Dermatology, 2018, v. 27, n. 9, p. 1038, doi. 10.1111/exd.13687

By:

Ning, Jinling;
Shen, Ying;
Wang, Ting;
Wang, Mengru;
Liu, Wei;
Sun, Yonghu;
Zhang, Furen;
Chen, Lingling;
Wang, Yiqiang

Publication type:

Article

Imiquimod chemoprophylaxis for field cancerization in xeroderma pigmentosum patients—A prospective study.

Published in:

Australasian Journal of Dermatology, 2023, v. 64, n. 3, p. 435, doi. 10.1111/ajd.14029

By:

Rocha, Lílian Kelly Faria Licarião;
Ferreira, Paula;
Gianotti, Marcelo A.;
Avancini, João;
Menck, Carlos F. M.;
Castro, Ligia P.;
de Oliveira, Zilda Najjar Prado;
Rivitti, Maria C.;
Samorano, Luciana P.;
Pereira, Naiura Vieira;
Festa Neto, Cyro

Publication type:

Article

Re: Reply to letter to the editor re: 'practical guide on the use of imiquimod cream to treat lentigo maligna'.

Published in:

Australasian Journal of Dermatology, 2022, v. 63, n. 2, p. e198, doi. 10.1111/ajd.13797

By:

Guitera, Pascale;
Waddell, Andreanne;
Paton, Elizabeth;
Fogarty, Gerald B;
Hong, Angela;
Scolyer, Richard A;
Stretch, Jonathan R;
O'Donnell, Brett A;
Pellacani, Giovanni

Publication type:

Article

Reply to: A practical guide on the use of imiquimod cream to treat lentigo maligna.

Published in:

Australasian Journal of Dermatology, 2022, v. 63, n. 2, p. e197, doi. 10.1111/ajd.13771

By:

Muir, James;
McCormack, Chris;
De'Ambrosis, Brian;
Brown, Hilary;
Kennedy, Daniel;
Louie, Brendan;
Smithers, B Mark

Publication type:

Article

A practical guide on the use of imiquimod cream to treat lentigo maligna.

Published in:

Australasian Journal of Dermatology, 2021, v. 62, n. 4, p. 478, doi. 10.1111/ajd.13720

By:

Guitera, Pascale;
Waddell, Andreanne;
Paton, Elizabeth;
Fogarty, Gerald B;
Hong, Angela;
Scolyer, Richard A;
Stretch, Jonathan R;
O'Donnell, Brett A;
Pellacani, Giovanni

Publication type:

Article

Immunotherapy for the treatment of penile intraepithelial neoplasia associated with human papilloma virus type 16 using topical imiquimod and human papilloma virus vaccination.

Published in:

Australasian Journal of Dermatology, 2021, v. 62, n. 4, p. e589, doi. 10.1111/ajd.13709

By:

Kim, Tae Yeb;
Das, Moushumi;
Poppito, Natalie;
Jarrett, Paul

Publication type:

Article

Anogenital giant condyloma in an infant with liver transplantation.

Published in:

Dermatology Online Journal, 2021, v. 27, n. 7, p. 1, doi. 10.5070/D327754374

By:

Masataka Satoh;
Toshiyuki Yamamoto

Publication type:

Article

Conservative treatment of lentigo maligna with topical imiquimod 5% cream: a case report.

Published in:

Dermatology Online Journal, 2020, v. 26, n. 7, p. 1, doi. 10.5070/d3267049569

By:

Lobo, Yolanka;
Templeman, Rupert

Publication type:

Article

Lifitegrast, a Lymphocyte Function‐Associated Antigen‐1 Antagonist Demonstrates Beneficial Effect in Psoriasis.

Published in:

Drug Development Research, 2024, v. 85, n. 8, p. 1, doi. 10.1002/ddr.70034

By:

Gawande, Rahul Sudhakar;
Rao Thakkalapally, Lakshmi;
Pethe, Anil M.

Publication type:

Article

Coptisine Alleviates Imiquimod-Induced Psoriasis-like Skin Lesions and Anxiety-like Behavior in Mice.

Published in:

Molecules, 2022, v. 27, n. 4, p. 1412, doi. 10.3390/molecules27041412

By:

Nguyen, Ly Thi Huong;
Choi, Min-Jin;
Shin, Heung-Mook;
Yang, In-Jun

Publication type:

Article

Correction: Vulvar's Paget's disease treated with a combination of clock mapping and imiquimod.

Published in:

2023

By:

Iavazzo, Christos;
Gkegkes, Ioannis D.;
Fotiou, Alexandros

Publication type:

Correction Notice

Vulvar's Paget's disease treated with a combination of clock mapping and imiquimod.

Published in:

2023

By:

Iavazzo, Christos;
Gkegkes, Ioannis D.;
Fotiou, Alexandros

Publication type:

Letter to the Editor

Stevens-Johnson syndrome due to topical imiquimod 5%.

Published in:

Australian Journal of General Practice, 2020, v. 49, n. 10, p. 662, doi. 10.31128/ajgp-11-19-5145

By:

Tedman, Alexander;
Malla, Utsav;
Vasanthakumar, Luke;
Buzacott, Katie;
Banney, Leith

Publication type:

Article

Imiquimod Reverses Chronic Toxoplasmosis-Associated Behavioral and Neurocognitive Anomalies in a Rat Model.

Published in:

Biomedicines, 2024, v. 12, n. 6, p. 1295, doi. 10.3390/biomedicines12061295

By:

Itani, Shaymaa;
Hamie, Maguy;
El Jammal, Reem;
Abdine, Wassim;
Doumit, Mark;
Charafeddine, Adib;
El-Sabban, Marwan;
Patinote, Cindy;
Masquefa, Carine;
Bonnet, Pierre-Antoine;
Obeid, Makram;
El Hajj, Hiba

Publication type:

Article

Atypical Fibroxanthoma Treated with a Topical Combination of Imiquimod, Tazarotene, and 5-Fluorouracil.

Published in:

2024

By:

Nahm, William J.;
Badiavas, Evangelos V.;
Kirsner, Robert S.;
Boyd, Carter J.;
Arthur, Anita A.;
Bae, Sean;
Shen, John

Publication type:

Case Study

Topical Treatment of Melanoma In Situ, Lentigo Maligna, and Lentigo Maligna Melanoma with Imiquimod Cream: A Systematic Review of the Literature.

Published in:

Dermatology & Therapy, 2023, v. 13, n. 10, p. 2187, doi. 10.1007/s13555-023-00993-1

By:

Vaienti, Silvia;
Calzari, Paolo;
Nazzaro, Gianluca

Publication type:

Article

Rare Cutaneous Side Effects of Imiquimod: A Review on Its Mechanisms, Diagnosis, and Management.

Published in:

Dermatology & Therapy, 2023, v. 13, n. 9, p. 1909, doi. 10.1007/s13555-023-00978-0

By:

Zhang, Xiaoyan;
Xie, Yao;
Wang, Lin

Publication type:

Article

Lentigo Maligna on a Difficult Location of the Face Treated with 5% Imiquimod: A Case Report of 2-Year Follow-Up.

Published in:

Dermatology & Therapy, 2022, v. 12, n. 2, p. 599, doi. 10.1007/s13555-021-00667-w

By:

Misiak-Galazka, Magdalena;
Czuwara, Joanna;
Galazka, Adam;
Czaplicka, Anna;
Rudnicka, Lidia

Publication type:

Article

Revisiting Imiquimod for Treatment of Folliculotropic Mycosis Fungoides: A Case Report and Review of the Literature.

Published in:

Dermatology & Therapy, 2019, v. 9, n. 4, p. 807, doi. 10.1007/s13555-019-00317-2

By:

Shalabi, Doaa;
Vadalia, Nish;
Nikbakht, Neda

Publication type:

Article

Abnormal composition of microbiota in the gut and skin of imiquimod-treated mice.

Published in:

Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-90480-4

By:

Shinno-Hashimoto, Hiroyo;
Hashimoto, Yaeko;
Wei, Yan;
Chang, Lijia;
Fujita, Yuko;
Ishima, Tamaki;
Matsue, Hiroyuki;
Hashimoto, Kenji

Publication type:

Article

Transcriptomic analysis identifies differences in gene expression in actinic keratoses after treatment with imiquimod and between responders and non responders.

Published in:

Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-88424-z

By:

Trager, Megan H.;
Rizk, Emanuelle;
Rose, Sharon;
Zhu, Kuixi;
Lau, Branden;
Fullerton, Benjamin T.;
Pradhan, Jaya;
Moore, Michael;
Srivastava, Ayush C.;
Singer, Giselle;
Gartrell, Robyn;
Chang, Rui;
Geskin, Larisa J.;
Saenger, Yvonne M.;
Goldenberg, Gary

Publication type:

Article

Topical application of endothelin receptor a antagonist attenuates imiquimod-induced psoriasiform skin inflammation.

Published in:

Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-66490-z

By:

Nakahara, Takeshi;
Kido-Nakahara, Makiko;
Ulzii, Dugarmaa;
Miake, Sho;
Fujishima, Kei;
Sakai, Sawako;
Chiba, Takahito;
Tsuji, Gaku;
Furue, Masutaka

Publication type:

Article

Treatment of Cutaneous Melanoma Harboring SMO p.Gln216Arg Mutation with Imiquimod: An Old Drug with New Results.

Published in:

Journal of Personalized Medicine, 2021, v. 11, n. 3, p. 206, doi. 10.3390/jpm11030206

By:

Troiani, Teresa;
Napolitano, Stefania;
Brancaccio, Gabriella;
Belli, Valentina;
Nappi, Annarita;
Miro, Caterina;
Salvatore, Domenico;
Dentice, Monica;
Caraglia, Michele;
Franco, Renato;
Giunta, Emilio Francesco;
De Falco, Vincenzo;
Ciardiello, Davide;
Ciardiello, Fortunato;
Argenziano, Giuseppe

Publication type:

Article

Topical imiquimod as neoadjuvant therapy before Mohs micrographic surgery for basal cell carcinoma in the head and neck region: findings from a large retrospective study.

Published in:

British Journal of Dermatology, 2021, v. 185, n. 4, p. 851, doi. 10.1111/bjd.20487

By:

Queirós, C.;
Silva, L.;
Miroux Catarino, A.;
Labareda, J.;
Catorze, G.;
Viana, I.

Publication type:

Article

Real‐world experience of off‐label use of imiquimod 5% as an adjuvant therapy after surgery or as a monotherapy for lentigo maligna.

Published in:

British Journal of Dermatology, 2021, v. 185, n. 3, p. 675, doi. 10.1111/bjd.20407

By:

Lallas, A.;
Moscarella, E.;
Kittler, H.;
Longo, C.;
Thomas, L.;
Zalaudek, I.;
Kyrgidis, A.;
Manoli, S.M.;
di Meo, N.;
Papageorgiou, C.;
Apalla, Z.;
Argenziano, G.

Publication type:

Article

Topical imiquimod monotherapy for a recurrent lesion of Merkel cell carcinoma.

Published in:

British Journal of Dermatology, 2021, v. 184, n. 2, p. e30, doi. 10.1111/bjd.19402

By:

Miura, H.;
Takada, M.;
Fujiwara, M.;
Fujiwara, S.

Publication type:

Article

Immunization with nanovaccines containing mutated K-Ras peptides and imiquimod aggravates heterotopic pancreatic cancer induced in mice.

Published in:

Frontiers in Immunology, 2023, v. 14, p. 1, doi. 10.3389/fimmu.2023.1153724

By:

Martínez-Pérez, Amparo;
Diego-González, Lara;
Vilanova, Manuel;
Correia, Alexandra;
Simón-Vázquez, Rosana;
González-Fernández, África

Publication type:

Article

Corrigendum: Co-stimulation with TLR7 agonist imiquimod and inactivated Influenza virus particles promotes mouse B cell activation, differentiation, and accelerated antigen specific antibody production .

Published in:

Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.1053779

By:

Can Li;
To, Kelvin K. W.;
Zhang, Anna J. X.;
Lee, Andrew C. Y.;
Houshun Zhu;
Mak, Winger W. N.;
Hung, Ivan F. N.;
Kwok-Yung Yuen

Publication type:

Article

A Murine Point Mutation of Sgpl1 Skin Is Enriched With Vγ6 IL17-Producing Cell and Revealed With Hyperpigmentation After Imiquimod Treatment.

Published in:

Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.728455

By:

Yang, Wenyi;
Zhou, Binhui;
Liu, Qi;
Liu, Taozhen;
Wang, Huijie;
Zhang, Pei;
Lu, Liaoxun;
Zhang, Lichen;
Zhang, Fanghui;
Huang, Rong;
Zhou, Jitong;
Chao, Tianzhu;
Gu, Yanrong;
Lee, Songhua;
Wang, Hui;
Liang, Yinming;
He, Le

Publication type:

Article

Different Spatial and Temporal Roles of Monocytes and Monocyte-Derived Cells in the Pathogenesis of an Imiquimod Induced Lupus Model.

Published in:

Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.764557

By:

Nomura, Atsushi;
Mizuno, Miho;
Noto, Daisuke;
Aoyama, Aki;
Kuga, Taiga;
Murayama, Goh;
Chiba, Asako;
Miyake, Sachiko

Publication type:

Article

Imiquimod‐induced extensive plaque psoriasis.

Published in:

International Journal of Dermatology, 2023, v. 62, n. 12, p. e614, doi. 10.1111/ijd.16820

By:

Abreu, Erica P.;
Schwan, Nicole V.;
Gontijo, João R. V.;
Bittencourt, Flávia V.

Publication type:

Article

Exacerbation of psoriatic arthritis due to topical imiquimod therapy.

Published in:

International Journal of Dermatology, 2023, v. 62, n. 3, p. e156, doi. 10.1111/ijd.16360

By:

Nakamura, Kentaro;
Arakawa, Yukiyasu;
Masuda, Koji;
Arita, Takahiro;
Katoh, Norito;
Asai, Jun

Publication type:

Article

Concerning the assessment of outcomes in the treatment of actinic cheilitis. Comment on: "Cheilitis Actinica: topical treatment with 3.75% imiquimod".

Published in:

International Journal of Dermatology, 2022, v. 61, n. 7, p. e241, doi. 10.1111/ijd.16248

By:

Garbers, Luiz Eduardo Fabrício de Melo;
Miola, Anna Carolina;
Miot, Hélio Amante

Publication type:

Article

Cheilitis Actinica: topical treatment with 3.75% imiquimod.

Published in:: International Journal of Dermatology, 2022, v. 61, n. 6, p. e198, doi. 10.1111/ijd.16150
Publication type:: Article

In lieu of penectomy: complete resolution of penile melanoma in situ with topical imiquimod and tretinoin.

Published in:

International Journal of Dermatology, 2021, v. 60, n. 8, p. e297, doi. 10.1111/ijd.15261

By:

O'Hern, Keegan;
Chambers, Meagan;
Ryan, Chenin;
Chapman, M. Shane

Publication type:

Article